113 related articles for article (PubMed ID: 8791999)
1. Transfection of murine fibroblast cells with human cytidine deaminase cDNA confers resistance to cytosine arabinoside.
Momparler RL; Laliberté J; Eliopoulos N; Beauséjour C; Cournoyer D
Anticancer Drugs; 1996 May; 7(3):266-74. PubMed ID: 8791999
[TBL] [Abstract][Full Text] [Related]
2. Resistance to cytosine arabinoside by retrovirally mediated gene transfer of human cytidine deaminase into murine fibroblast and hematopoietic cells.
Momparler RL; Eliopoulos N; Bovenzi V; Létourneau S; Greenbaum M; Cournoyer D
Cancer Gene Ther; 1996; 3(5):331-8. PubMed ID: 8894252
[TBL] [Abstract][Full Text] [Related]
3. Drug resistance to 5-aza-2'-deoxycytidine, 2',2'-difluorodeoxycytidine, and cytosine arabinoside conferred by retroviral-mediated transfer of human cytidine deaminase cDNA into murine cells.
Eliopoulos N; Cournoyer D; Momparler RL
Cancer Chemother Pharmacol; 1998; 42(5):373-8. PubMed ID: 9771951
[TBL] [Abstract][Full Text] [Related]
4. Coexpression of rat glutathione S-transferase A3 and human cytidine deaminase by a bicistronic retroviral vector confers in vitro resistance to nitrogen mustards and cytosine arabinoside in murine fibroblasts.
Létourneau S; Palerme JS; Delisle JS; Beauséjour CM; Momparler RL; Cournoyer D
Cancer Gene Ther; 2000 May; 7(5):757-65. PubMed ID: 10830723
[TBL] [Abstract][Full Text] [Related]
5. Forced expression of cytidine deaminase confers resistance to cytosine arabinoside and gemcitabine.
Neff T; Blau CA
Exp Hematol; 1996 Sep; 24(11):1340-6. PubMed ID: 8862446
[TBL] [Abstract][Full Text] [Related]
6. Coexpression of cytidine deaminase and mutant dihydrofolate reductase by a bicistronic retroviral vector confers resistance to cytosine arabinoside and methotrexate.
Beauséjour CM; Le NL; Létourneau S; Cournoyer D; Momparler RL
Hum Gene Ther; 1998 Nov; 9(17):2537-44. PubMed ID: 9853520
[TBL] [Abstract][Full Text] [Related]
7. Selection of drug-resistant transduced cells with cytosine nucleoside analogs using the human cytidine deaminase gene.
Beauséjour CM; Eliopoulos N; Momparler L; Le NL; Momparler RL
Cancer Gene Ther; 2001 Sep; 8(9):669-76. PubMed ID: 11593336
[TBL] [Abstract][Full Text] [Related]
8. Retroviral transfer and long-term expression of human cytidine deaminase cDNA in hematopoietic cells following transplantation in mice.
Eliopoulos N; Bovenzi V; Le NL; Momparler LF; Greenbaum M; Létourneau S; Cournoyer D; Momparler RL
Gene Ther; 1998 Nov; 5(11):1545-51. PubMed ID: 9930308
[TBL] [Abstract][Full Text] [Related]
9. Constitutive overexpression of the cytidine deaminase gene confers resistance to cytosine arabinoside in vitro.
Schröder JK; Kirch C; Flasshove M; Kalweit H; Seidelmann M; Hilger R; Seeber S; Schütte J
Leukemia; 1996 Dec; 10(12):1919-24. PubMed ID: 8946931
[TBL] [Abstract][Full Text] [Related]
10. [Mice transduced with double-mutant dihydrofolate reductase-cytidine deaminase fusion gene attained protection from high dose chemotherapy].
Lu P; Lu Y; Pang K; Wang SB; Chen JQ; Xu HM; Wang JK; Zhao SC
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):998-1001. PubMed ID: 16194358
[TBL] [Abstract][Full Text] [Related]
11. Gene amplification of human cytidine deaminase proviral cDNA and increased levels of its mRNA produces enhanced drug resistance to cytosine arabinoside in retroviral-transduced murine fibroblasts.
Beauséjour CM; Momparler RL
Cancer Lett; 1999 Jan; 135(1):29-36. PubMed ID: 10077218
[TBL] [Abstract][Full Text] [Related]
12. Expression of a novel double-mutant dihydrofolate reductase-cytidine deaminase fusion gene confers resistance to both methotrexate and cytosine arabinoside.
Sauerbrey A; McPherson JP; Zhao SC; Banerjee D; Bertino JR
Hum Gene Ther; 1999 Oct; 10(15):2495-504. PubMed ID: 10543614
[TBL] [Abstract][Full Text] [Related]
13. Transfer of the cytidine deaminase cDNA into hematopoietic cells.
Flasshove M; Frings W; Schröder JK; Moritz T; Schütte J; Seeber S
Leuk Res; 1999 Nov; 23(11):1047-53. PubMed ID: 10576510
[TBL] [Abstract][Full Text] [Related]
14. Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone marrow stromal cells.
Eliopoulos N; Al-Khaldi A; Beauséjour CM; Momparler RL; Momparler LF; Galipeau J
Gene Ther; 2002 Apr; 9(7):452-62. PubMed ID: 11938460
[TBL] [Abstract][Full Text] [Related]
15. GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia.
Ge Y; Stout ML; Tatman DA; Jensen TL; Buck S; Thomas RL; Ravindranath Y; Matherly LH; Taub JW
J Natl Cancer Inst; 2005 Feb; 97(3):226-31. PubMed ID: 15687366
[TBL] [Abstract][Full Text] [Related]
16. Chemoprotection of murine hematopoietic cells by combined gene transfer of cytidine deaminase (CDD) and multidrug resistance 1 gene (MDR1).
Brennig S; Lachmann N; Buchegger T; Hetzel M; Schambach A; Moritz T
J Exp Clin Cancer Res; 2015 Dec; 34():148. PubMed ID: 26651614
[TBL] [Abstract][Full Text] [Related]
17. In vivo enrichment of cytidine deaminase gene-modified hematopoietic cells by prolonged cytosine-arabinoside application.
Brennig S; Rattmann I; Lachmann N; Schambach A; Williams DA; Moritz T
Cytotherapy; 2012 Apr; 14(4):451-60. PubMed ID: 22242831
[TBL] [Abstract][Full Text] [Related]
18. Recombinant gene products of two natural variants of the human cytidine deaminase gene confer different deamination rates of cytarabine in vitro.
Kirch HC; Schröder J; Hoppe H; Esche H; Seeber S; Schütte J
Exp Hematol; 1998 May; 26(5):421-5. PubMed ID: 9590659
[TBL] [Abstract][Full Text] [Related]
19. Creation of zebularine-resistant human cytidine deaminase mutants to enhance the chemoprotection of hematopoietic stem cells.
Ruan H; Qiu S; Beard BC; Black ME
Protein Eng Des Sel; 2016 Dec; 29(12):573-582. PubMed ID: 27160178
[TBL] [Abstract][Full Text] [Related]
20. Assessment of resistance induction to cytosine arabinoside following transfer and overexpression of the deoxycytidylate deaminase gene in vitro.
Schröder JK; Seidelmann M; Kirch HC; Seeber S; Schütte J
Leuk Res; 1998 Jul; 22(7):619-24. PubMed ID: 9680112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
